to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection
Clinical trial NCT06437951 · UNKNOWN
Trial details
- NCT number
- NCT06437951
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2025-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.